Alnylam Pharmaceuticals
$23.52 B
Share price
Change (1 day)
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Number of shares outstanding for Alnylam Pharmaceuticals (ALNY)

Number of shares outstanding as of June 2023 : 124,111,000

According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 124,111,000. At the end of 2023 the company had 124,111,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alnylam Pharmaceuticals from 2003 to 2023

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20230.12 B0.69%
20220.12 B2.92%
20210.11 B3.01%
20200.11 B4.05%
20190.11 B10.57%
20180.10 B5.12%
201796.13 M11.99%
201685.84 M1.15%
201584.87 M10.28%
201476.95 M22.33%
201362.9 M21.4%
201251.82 M21.49%
201142.65 M1.26%
201042.12 M1%
200941.7 M1.24%
200841.19 M5.57%
200739.02 M21.49%
200632.12 M53.59%
200520.91 M7.21%
200419.5 M2209.85%
20030.84 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
2,110,000,000 1,600.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
2,508,000,000 1,920.77%๐Ÿ‡ซ๐Ÿ‡ท France
107,100,000-13.71%๐Ÿ‡บ๐Ÿ‡ธ USA
88,186,000-28.95%๐Ÿ‡บ๐Ÿ‡ธ USA
16,839,700-86.43%๐Ÿ‡บ๐Ÿ‡ธ USA
751,506,257 505.51%๐Ÿ‡บ๐Ÿ‡ธ USA
1,111,000,000 795.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
106,757,000-13.98%๐Ÿ‡บ๐Ÿ‡ธ USA